HBsAg-话题@MedSci

#HBsAg#

30篇内容 | 6108人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2311495, encodeId=1b242311495f3, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=5423139864bc' target=_blank style='color:#2F92EE;'>#APASL2026#</a>, objectTitle=APASL2026丨非活动性HBsAg携带人群随访20余年仍有疾病进展的风险, objectType=article, longId=937686, objectId=da6693e68681, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240621/1718952141916_5579292.png, objectUrl=/article/show_article.do?id=da6693e68681, replyNumber=0, likeNumber=2, createdTime=12小时前, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=da6693e68681, moduleTitle=APASL2026丨非活动性HBsAg携带人群随访20余年仍有疾病进展的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=da6693e68681)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2307004, encodeId=986c230e004ec, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【期刊导读】NA经治慢乙肝患者加用聚乙二醇干扰素α-2b治疗48周HBsAg清除率为30.4%，停药24周复发率为0, objectType=article, longId=934209, objectId=5c399342090f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240522/1716373845687_5579292.jpg, objectUrl=/article/show_article.do?id=5c399342090f, replyNumber=0, likeNumber=21, createdTime=2026-04-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=5c399342090f, moduleTitle=【期刊导读】NA经治慢乙肝患者加用聚乙二醇干扰素α-2b治疗48周HBsAg清除率为30.4%，停药24周复发率为0, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5c399342090f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2305790, encodeId=f4d22305e909d, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【期刊导读】荟萃分析：HBsAg < 100 IU/mL的慢乙肝患者自发性HBsAg清除的年发生率仅4.58%, objectType=article, longId=931470, objectId=02a19314e052, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240624/1719201193789_92910.png, objectUrl=/article/show_article.do?id=02a19314e052, replyNumber=0, likeNumber=32, createdTime=2026-03-31, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=02a19314e052, moduleTitle=【期刊导读】荟萃分析：HBsAg < 100 IU/mL的慢乙肝患者自发性HBsAg清除的年发生率仅4.58%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=02a19314e052)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2305378, encodeId=e5f823053e89c, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【期刊导读】基于多项RCT研究的荟萃分析：Peg IFNα联合NAs治疗慢乙肝显著提高HBsAg清除率及血清学转换率, objectType=article, longId=931324, objectId=af5993132486, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250114/1736847778037_8538692.png, objectUrl=/article/show_article.do?id=af5993132486, replyNumber=0, likeNumber=25, createdTime=2026-03-27, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=af5993132486, moduleTitle=【期刊导读】基于多项RCT研究的荟萃分析：Peg IFNα联合NAs治疗慢乙肝显著提高HBsAg清除率及血清学转换率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=af5993132486)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2303099, encodeId=0c8e23030990c, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=c59480e81c7' target=_blank style='color:#2F92EE;'>#聚乙二醇干扰素α#</a>, objectTitle=【期刊导读】高分个体数据荟萃分析：聚乙二醇干扰素α联合核苷（酸）类似物可显著提升HBsAg清除率，基线HBsAg水平是关键预测因素, objectType=article, longId=928708, objectId=acd2928e0811, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240627/1719481658993_92910.png, objectUrl=/article/show_article.do?id=acd2928e0811, replyNumber=0, likeNumber=73, createdTime=2026-03-10, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=acd2928e0811, moduleTitle=【期刊导读】高分个体数据荟萃分析：聚乙二醇干扰素α联合核苷（酸）类似物可显著提升HBsAg清除率，基线HBsAg水平是关键预测因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=acd2928e0811)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2302627, encodeId=9352230262e31, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=aa791400831' target=_blank style='color:#2F92EE;'>#pegIFNα#</a>, objectTitle=【期刊导读】宁琴/吴迪教授团队Anchor研究结果发表：NA经治HBsAg < 3000 IU/mL患者基于PegIFNα治疗后停药24周的HBsAg清除率近30%, objectType=article, longId=928141, objectId=be209281418b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240708/1720420864050_92910.png, objectUrl=/article/show_article.do?id=be209281418b, replyNumber=0, likeNumber=49, createdTime=2026-03-06, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=be209281418b, moduleTitle=【期刊导读】宁琴/吴迪教授团队Anchor研究结果发表：NA经治HBsAg < 3000 IU/mL患者基于PegIFNα治疗后停药24周的HBsAg清除率近30%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=be209281418b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2299944, encodeId=2ddb229994473, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【期刊导读】ASAP-12评分模型：可早期识别有望实现HBsAg清除与血清学转换的优势患者, objectType=article, longId=924727, objectId=df76924e270b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250114/1736847778037_8538692.png, objectUrl=/article/show_article.do?id=df76924e270b, replyNumber=0, likeNumber=70, createdTime=2026-02-06, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=df76924e270b, moduleTitle=【期刊导读】ASAP-12评分模型：可早期识别有望实现HBsAg清除与血清学转换的优势患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df76924e270b)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2298449, encodeId=dc642298449f2, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=1315194e2b7' target=_blank style='color:#2F92EE;'>#丁型肝炎病毒#</a> <a href='/topic/show?id=108313621246' target=_blank style='color:#2F92EE;'>#Tobevibart#</a> <a href='/topic/show?id=3fa8136213a4' target=_blank style='color:#2F92EE;'>#Elebsiran#</a>, objectTitle=NEJM | 新组合疗法有望改写丁型肝炎病毒治疗格局：Tobevibart联合Elebsiran展现显著抗病毒潜力, objectType=article, longId=923048, objectId=20659230485c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250122/1737543636981_8538692.jpg, objectUrl=/article/show_article.do?id=20659230485c, replyNumber=0, likeNumber=50, createdTime=2026-01-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=20659230485c, moduleTitle=NEJM | 新组合疗法有望改写丁型肝炎病毒治疗格局：Tobevibart联合Elebsiran展现显著抗病毒潜力, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=20659230485c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2297399, encodeId=e840229e39962, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【愈见乙肝2025】有肝癌家族史的核苷经治慢乙肝患者经联合治疗并合理应对不良反应，获得HBsAg血清学转换, objectType=article, longId=921125, objectId=e380921125f2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202401030/1730265935847_8538692.jpg, objectUrl=/article/show_article.do?id=e380921125f2, replyNumber=1, likeNumber=75, createdTime=2026-01-16, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e380921125f2, moduleTitle=【愈见乙肝2025】有肝癌家族史的核苷经治慢乙肝患者经联合治疗并合理应对不良反应，获得HBsAg血清学转换, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e380921125f2)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2296106, encodeId=3f29229610652, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=fab46121efa' target=_blank style='color:#2F92EE;'>#机器学习模型#</a>, objectTitle=【期刊导读】陈新月/郑素军教授团队：机器学习模型预测IHC人群接受PEG IFNα治疗的HBsAg清除, objectType=article, longId=918396, objectId=cba9918396e0, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240713/1720882052776_5579292.png, objectUrl=/article/show_article.do?id=cba9918396e0, replyNumber=0, likeNumber=76, createdTime=2026-01-06, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=cba9918396e0, moduleTitle=【期刊导读】陈新月/郑素军教授团队：机器学习模型预测IHC人群接受PEG IFNα治疗的HBsAg清除, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cba9918396e0)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2294738, encodeId=925f2294e3804, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=c59480e81c7' target=_blank style='color:#2F92EE;'>#聚乙二醇干扰素α#</a>, objectTitle=【期刊导读】侯金林/樊蓉教授团队：GOLDEN模型可预测聚乙二醇干扰素α治疗获HBsAg清除的概率, objectType=article, longId=917975, objectId=fa8091e975cf, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240521/1716259408769_5579292.jpg, objectUrl=/article/show_article.do?id=fa8091e975cf, replyNumber=0, likeNumber=76, createdTime=2025-12-26, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=fa8091e975cf, moduleTitle=【期刊导读】侯金林/樊蓉教授团队：GOLDEN模型可预测聚乙二醇干扰素α治疗获HBsAg清除的概率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fa8091e975cf)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2293914, encodeId=2764229391471, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【期刊导读】机制探索：获得HBsAg清除后，为何部分患者的HBeAg/HBV DNA仍呈阳性？, objectType=article, longId=916911, objectId=a0639169118a, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867598346_4754896.jpeg, objectUrl=/article/show_article.do?id=a0639169118a, replyNumber=0, likeNumber=0, createdTime=2025-12-19, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=a0639169118a, moduleTitle=【期刊导读】机制探索：获得HBsAg清除后，为何部分患者的HBeAg/HBV DNA仍呈阳性？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a0639169118a)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2293342, encodeId=77f422933427d, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=73cf131292cc' target=_blank style='color:#2F92EE;'>#AASLD 2025#</a>, objectTitle=AASLD2025丨核苷停药复发风险较高，且HBsAg清除率低, objectType=article, longId=914772, objectId=1f38914e7251, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240628/1719539714497_5579292.jpg, objectUrl=/article/show_article.do?id=1f38914e7251, replyNumber=0, likeNumber=65, createdTime=2025-12-15, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=1f38914e7251, moduleTitle=AASLD2025丨核苷停药复发风险较高，且HBsAg清除率低, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1f38914e7251)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2292073, encodeId=3c4322920e3f5, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=474513102ee6' target=_blank style='color:#2F92EE;'>#AASLD2025#</a>, objectTitle=AASLD2025丨HBsAg清除持久性好，5年HBsAg血清学逆转仅1%, objectType=article, longId=911543, objectId=0797911543eb, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/filling-medical-history-XZB9RVX.jpg, objectUrl=/article/show_article.do?id=0797911543eb, replyNumber=0, likeNumber=71, createdTime=2025-12-05, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=0797911543eb, moduleTitle=AASLD2025丨HBsAg清除持久性好，5年HBsAg血清学逆转仅1%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0797911543eb)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2289222, encodeId=a2a62289222e9, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=3d745346316' target=_blank style='color:#2F92EE;'>#慢性乙型肝炎#</a>, objectTitle=明明应用干扰素追求CHB功能性治愈，为什么患者HBsAg水平不降反增？（下）, objectType=article, longId=907725, objectId=76c090e725b0, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867576310_4754896.jpeg, objectUrl=/article/show_article.do?id=76c090e725b0, replyNumber=1, likeNumber=75, createdTime=2025-11-17, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=76c090e725b0, moduleTitle=明明应用干扰素追求CHB功能性治愈，为什么患者HBsAg水平不降反增？（下）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=76c090e725b0)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2280993, encodeId=c34d22809939f, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【愈见乙肝2025】HBsAg低水平的HBeAg阴性不确定期慢乙肝患者经短期联合治疗即获HBsAg血清学转换, objectType=article, longId=894030, objectId=152689403003, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230326/1679867576310_4754896.jpeg, objectUrl=/article/show_article.do?id=152689403003, replyNumber=0, likeNumber=80, createdTime=2025-09-12, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=152689403003, moduleTitle=【愈见乙肝2025】HBsAg低水平的HBeAg阴性不确定期慢乙肝患者经短期联合治疗即获HBsAg血清学转换, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=152689403003)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2279418, encodeId=6f6222e941889, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=974b129e596b' target=_blank style='color:#2F92EE;'>#PEG-IFNα-2b#</a>, objectTitle=临床研究｜PEG-IFNα-2b治疗非活动性HBsAg携带者血清TNF-α水平的变化趋势及其与HBsAg清除的关系, objectType=article, longId=892768, objectId=0266892e68d2, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250114/1736847778037_8538692.png, objectUrl=/article/show_article.do?id=0266892e68d2, replyNumber=0, likeNumber=67, createdTime=2025-08-31, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=0266892e68d2, moduleTitle=临床研究｜PEG-IFNα-2b治疗非活动性HBsAg携带者血清TNF-α水平的变化趋势及其与HBsAg清除的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0266892e68d2)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2278137, encodeId=a42a22e8137a4, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【期刊导读】可溶性PD-1可作为预测慢乙肝患者HBsAg清除的潜在生物标志物, objectType=article, longId=892066, objectId=e00389206606, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240827/1724750166404_8538692.png, objectUrl=/article/show_article.do?id=e00389206606, replyNumber=0, likeNumber=75, createdTime=2025-08-21, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=e00389206606, moduleTitle=【期刊导读】可溶性PD-1可作为预测慢乙肝患者HBsAg清除的潜在生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e00389206606)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2277219, encodeId=2abb22e7219d5, content=<a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a> <a href='/topic/show?id=315a5342562' target=_blank style='color:#2F92EE;'>#慢乙肝#</a>, objectTitle=【期刊导读】再次证实：50岁前获得HBsAg清除可显著降低慢乙肝患者的进展期肝纤维化或肝硬化风险, objectType=article, longId=891482, objectId=1aa7891482c1, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20250114/1736847778037_8538692.png, objectUrl=/article/show_article.do?id=1aa7891482c1, replyNumber=0, likeNumber=72, createdTime=2025-08-14, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=1aa7891482c1, moduleTitle=【期刊导读】再次证实：50岁前获得HBsAg清除可显著降低慢乙肝患者的进展期肝纤维化或肝硬化风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1aa7891482c1)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2275387, encodeId=b16722e5387d9, content=<a href='/topic/show?id=cf292341925' target=_blank style='color:#2F92EE;'>#乙肝#</a> <a href='/topic/show?id=e803851e58' target=_blank style='color:#2F92EE;'>#HBsAg#</a>, objectTitle=【期刊导读】长期随访结果：PegIFNα治疗诱导的HBsAg清除持久性佳，停药后长期随访的HBsAg清除持久率约85%, objectType=article, longId=889427, objectId=df2588942e4e, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240627/1719489899523_2570354.png, objectUrl=/article/show_article.do?id=df2588942e4e, replyNumber=0, likeNumber=110, createdTime=2025-07-30, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=df2588942e4e, moduleTitle=【期刊导读】长期随访结果：PegIFNα治疗诱导的HBsAg清除持久性佳，停药后长期随访的HBsAg清除持久率约85%, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=df2588942e4e)], followStatus=false, userIsMember=false, type=null, lengthMark=0)] 梅斯话题小助手

HBsAg

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #APASL2026#

APASL2026丨非活动性HBsAg携带人群随访20余年仍有疾病进展的风险

12小时前发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝#

【期刊导读】NA经治慢乙肝患者加用聚乙二醇干扰素α-2b治疗48周HBsAg清除率为30.4%，停药24周复发率为0

2026-04-10发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝#

【期刊导读】荟萃分析：HBsAg < 100 IU/mL的慢乙肝患者自发性HBsAg清除的年发生率仅4.58%

2026-03-31发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝#

【期刊导读】基于多项RCT研究的荟萃分析：Peg IFNα联合NAs治疗慢乙肝显著提高HBsAg清除率及血清学转换率

2026-03-27发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #聚乙二醇干扰素α#

【期刊导读】高分个体数据荟萃分析：聚乙二醇干扰素α联合核苷（酸）类似物可显著提升HBsAg清除率，基线HBsAg水平是关键预测因素

2026-03-10发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #pegIFNα#

【期刊导读】宁琴/吴迪教授团队Anchor研究结果发表：NA经治HBsAg < 3000 IU/mL患者基于PegIFNα治疗后停药24周的HBsAg清除率近30%

2026-03-06发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝#

【期刊导读】ASAP-12评分模型：可早期识别有望实现HBsAg清除与血清学转换的优势患者

2026-02-06发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #丁型肝炎病毒# #Tobevibart# #Elebsiran#

NEJM | 新组合疗法有望改写丁型肝炎病毒治疗格局：Tobevibart联合Elebsiran展现显著抗病毒潜力

2026-01-24发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝#

【愈见乙肝2025】有肝癌家族史的核苷经治慢乙肝患者经联合治疗并合理应对不良反应，获得HBsAg血清学转换

2026-01-16发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #机器学习模型#

【期刊导读】陈新月/郑素军教授团队：机器学习模型预测IHC人群接受PEG IFNα治疗的HBsAg清除

2026-01-06发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #聚乙二醇干扰素α#

【期刊导读】侯金林/樊蓉教授团队：GOLDEN模型可预测聚乙二醇干扰素α治疗获HBsAg清除的概率

2025-12-26发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝#

【期刊导读】机制探索：获得HBsAg清除后，为何部分患者的HBeAg/HBV DNA仍呈阳性？

2025-12-19发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #AASLD 2025#

AASLD2025丨核苷停药复发风险较高，且HBsAg清除率低

2025-12-15发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #AASLD2025#

AASLD2025丨HBsAg清除持久性好，5年HBsAg血清学逆转仅1%

2025-12-05发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢性乙型肝炎#

明明应用干扰素追求CHB功能性治愈，为什么患者HBsAg水平不降反增？（下）

2025-11-17发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝#

【愈见乙肝2025】HBsAg低水平的HBeAg阴性不确定期慢乙肝患者经短期联合治疗即获HBsAg血清学转换

2025-09-12发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #PEG-IFNα-2b#

临床研究｜PEG-IFNα-2b治疗非活动性HBsAg携带者血清TNF-α水平的变化趋势及其与HBsAg清除的关系

2025-08-31发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝#

【期刊导读】可溶性PD-1可作为预测慢乙肝患者HBsAg清除的潜在生物标志物

2025-08-21发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#HBsAg# #慢乙肝#

【期刊导读】再次证实：50岁前获得HBsAg清除可显著降低慢乙肝患者的进展期肝纤维化或肝硬化风险

2025-08-14发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#乙肝# #HBsAg#

【期刊导读】长期随访结果：PegIFNα治疗诱导的HBsAg清除持久性佳，停药后长期随访的HBsAg清除持久率约85%

2025-07-30发表于上海

科室
- - 订阅+
  - 更多科室
工具
服务